ESR1 and breast carcinoma: Specifically, AI/AN women had 2.3 fold higher odds of presenting with stage IV breast cancer compared with non-Hispanic White women, and 1.3 fold higher odds of being diagnosed with estrogen receptor (ER)-/progesterone receptor (PR)- breast cancer compared with non-Hispanic White women [4].